Literature DB >> 6967790

Reduced T-lymphocyte subsets in systemic lupus erythematosus: effects of immune complexes and lymphocytotoxic antibodies.

R J DeHoratius, K S Tung, T Pincus.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6967790     DOI: 10.1016/0090-1229(80)90093-8

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


× No keyword cloud information.
  7 in total

1.  Specific suppression of anti-DNA production in vitro.

Authors:  M R Liebling; C Wong; J Radosevich; J S Louie
Journal:  J Clin Immunol       Date:  1988-09       Impact factor: 8.317

2.  Lymphocytotoxic antibody in multiple sclerosis: activity against T cell subsets and correlation with disease activity.

Authors:  C F Scott; L E Spitler
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

3.  Biological activity of lymphocytotoxic antibodies in Graves' disease and Hashimoto's thyroiditis.

Authors:  W Pruzanski; H Capes; R Baur; B E Wenzel; V V Row; R Volpé
Journal:  J Endocrinol Invest       Date:  1984-02       Impact factor: 4.256

4.  Alteration of Fc-receptor phenotype and proliferative capacity of Fc-IgG-receptor positive lymphocytes through interaction with soluble immune complexes of patients with SLE or RA.

Authors:  M Thien; D Renger; H Deicher; W J Pichler
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

5.  Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.

Authors:  D B Cines; A P Lyss; M Reeber; M Bina; R J DeHoratius
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

6.  Cytotoxic responses to alloantigens in systemic lupus erythematosus.

Authors:  G C Tsokos; J E Balow
Journal:  J Clin Immunol       Date:  1981-10       Impact factor: 8.317

7.  Deficient autologous mixed lymphocyte reactions correlate with disease activity in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  J B Smith; R J DeHoratius
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.